215 related articles for article (PubMed ID: 4262824)
21. S.M.O.N.
Spillane JD
Lancet; 1972 Jan; 1(7742):154. PubMed ID: 4109013
[No Abstract] [Full Text] [Related]
22. [A iatrogenic disease... subacute myelo-optico-neuropathy].
Degos CF; Thomas-Lamotte PJ
Rev Prat; 1977 Jun; 27(35):2277-85. PubMed ID: 143057
[No Abstract] [Full Text] [Related]
23. Relation between subacute myelo-optic neuropathy (S.M.O.N.) and clioquinol: nationwide survey.
Nakae K; Yamamoto S; Shigematsu I; Kono R
Lancet; 1973 Jan; 1(7796):171-3. PubMed ID: 4118793
[No Abstract] [Full Text] [Related]
24. Assessment of neurotoxicity of clioquinol (Enterovioform) by visual evoked potentials. A preliminary communication.
Bhasin DK; Raina R; Mehta SK; Arora MM
Indian J Gastroenterol; 1985 Jul; 4(3):165-6. PubMed ID: 3160659
[No Abstract] [Full Text] [Related]
25. Subacute myelo-optic neuropathy in Australia.
Selby G
Lancet; 1972 Jan; 1(7742):123-5. PubMed ID: 4108984
[No Abstract] [Full Text] [Related]
26. [Subacute myelo-optic-neuropathy during treatment with chloro-iodo-hydroxyquinoleine (author's transl)].
Charasz N; Vacherot B; Dougados M; Bousser MG; Belaiche J; Cattan D
Gastroenterol Clin Biol; 1979 Apr; 3(4):371-4. PubMed ID: 159200
[No Abstract] [Full Text] [Related]
27. Sub-acute myelo-optico neuropathy (a case report).
Mathew R; Gupta PS
J Assoc Physicians India; 1978 Jun; 26(6):547-8. PubMed ID: 152755
[No Abstract] [Full Text] [Related]
28. [Neurotoxicity of chinoform].
Iwashita H
Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):602-5. PubMed ID: 10434730
[No Abstract] [Full Text] [Related]
29. Clioquinol's return: cautions from Japan.
Tabira T
Science; 2001 Jun; 292(5525):2251-2. PubMed ID: 11424945
[No Abstract] [Full Text] [Related]
30. Warning on diiodohydroxyquin.
Med Lett Drugs Ther; 1974 Aug; 16(17):71-2. PubMed ID: 4276320
[No Abstract] [Full Text] [Related]
31. Going abroad.
Roe WP
Br Med J; 1972 Jun; 2(5816):770. PubMed ID: 4260938
[No Abstract] [Full Text] [Related]
32. Data on clioquinol and S.M.O.N.
Lee JA
Lancet; 1978 Sep; 2(8092 Pt 1):738. PubMed ID: 80663
[No Abstract] [Full Text] [Related]
33. Data on clioquinol and S.M.O.N.
Shigematsu I; Yanagawa H
Lancet; 1978 Oct; 2(8096):945. PubMed ID: 81960
[No Abstract] [Full Text] [Related]
34. Idiosyncratic neurotoxicity: clioquinol and bismuth.
Lancet; 1980 Apr; 1(8173):857-8. PubMed ID: 6103216
[No Abstract] [Full Text] [Related]
35. Relationship between neurological symptoms and concentrations of clioquinol in serum and nervous systems of beagle dogs.
Hayakawa K; Imanari T; Tamura Z; Kuroda S; Ikeda H; Tateishi J
Chem Pharm Bull (Tokyo); 1977 Aug; 25(8):2013-8. PubMed ID: 144569
[No Abstract] [Full Text] [Related]
36. Neurotoxicity of clioquinol. 1. Oral administration of clioquinol to several species of animals.
Tateishi J; Kuroda S; Saito A; Otsuki S
Seishin Shinkeigaku Zasshi; 1972 Sep; 74(9):739-55. PubMed ID: 4630865
[No Abstract] [Full Text] [Related]
37. Clioquinol and S.M.O.N.: Reanalysis of original data.
Asao M
Lancet; 1979 Feb; 1(8113):446. PubMed ID: 84300
[No Abstract] [Full Text] [Related]
38. Clioquinol intoxication occurring in the treatment of acrodermatitis enteropathica with reference to SMON outside of Japan.
Hanakago R; Uono M
Clin Toxicol; 1981 Dec; 18(12):1427-34. PubMed ID: 6460590
[TBL] [Abstract][Full Text] [Related]
39. SMON and other socially induced diseases in Japan.
Sonoda K
Soc Sci Med (1967); 1978 Nov; 12(6A):497-506. PubMed ID: 153585
[No Abstract] [Full Text] [Related]
40. [Subacute myelo-optic-neuropathy (S.M.O.N.) following treatment with clioquinol (author's transl)].
Mamoli B; Thaler A; Heilig P; Siakos G
J Neurol; 1975 Jun; 209(2):139-47. PubMed ID: 51051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
